Abstract: A system for medical detection and treatment comprising a number of treatment and/or detection devices which exchange data with each other within the context of a medical treatment, in particular a surgical or radiotherapeutic and/or radiosurgical operation, wherein the data are exchanged via radio interfaces in and/or on the devices.

Abstract: The present invention describes a process for the preparation of ethyldimethylamine and triethylamine with the following steps: (i) reaction of a mixture of diethylamine and dimethylamine with ethylene in the presence of a catalyst from the group of alkali metal dimethylamides, alkali metal diethylamides and alkali metal hydrides (ii) removal of the catalyst (iii) distillation separation of the resulting mixture in triethylamine and ethyldimethylamine and optionally diethylamine and dimethylamine (iv) optional return of the catalyst and of the starting amines to the reaction. The process according to the invention permits the coproduction of ethyldimethylamine and diethylamine in a simple process.

Abstract: A substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-one, compound of formula 1, wherein R1, R2, R3, R4 and R5 are as defined herein, pharmaceutical composition comprising the compound and use of the compound for inhibiting pancreatic lipase, or the prophylaxis or treatment of obesity are described.

Abstract: The present invention relates to stable thixotropic polysuccinimide (PSI) dispersions, known as slurries, and to their use as additives for improving the flow properties of concrete, in oil wells, in acidic gel cleaners, and in drainage systems of tunnel constructions.

Abstract: A system for medical detection and treatment comprising a number of treatment and/or detection devices which exchange data with each other within the context of a medical treatment, in particular a surgical or radiotherapeutic and/or radiosurgical operation, wherein the data are exchanged via radio interfaces in and/or on the devices.

Abstract: A method and system of controlling a vacuum-driven actuator in a vehicle. The method includes determining an amount of vacuum available to actuate the actuator, determining whether the available vacuum is sufficient to actuate the actuator, actuating the actuator only when the available vacuum is sufficient, and preventing actuation of the actuator when the available vacuum is insufficient.

Abstract: A method and system of controlling a vacuum-driven actuator in a vehicle. The method includes determining an amount of vacuum available to actuate the actuator, determining whether the available vacuum is sufficient to actuate the actuator, actuating the actuator only when the available vacuum is sufficient, and preventing actuation of the actuator when the available vacuum is insufficient.

Abstract: The invention relates to pharmaceutical agents containing leptin antagonists for treating Type II diabetes. One leptin antagonist is based on a murine leptin fragment and comprises amino acids 116 to 167 or 116 to 166. Methods of treating Type II diabetes are also disclosed.

Abstract: The invention is directed to an electronic control apparatus for forming a fuel-metering signal for an internal combustion engine wherein increased fuel metering occurs during the start and post-start phases of the engine. With the electronic control apparatus, an index is formed for the pressure in the intake manifold of the engine and the gradient of the index is formed. The increased metering of fuel is reduced in dependence upon the gradient.